Summary: Eclipse with AAA is a treatment planning system by Varian Medical Systems, primarily used in radiotherapy. Key evidence highlights its use in dose calculation accuracy, especially in complex scenarios involving high-density materials.
Eclipse with AAA was cleared by the FDA through the 510(k) pathway on July 26, 2004. It is manufactured by Varian Medical Systems and classified as a Class 2 device.
What It Is
Eclipse with AAA is a treatment planning system used in radiotherapy to calculate dose distributions. It employs the Anisotropic Analytical Algorithm (AAA) to model radiation dose delivery, particularly in complex anatomical scenarios.
Clinical Applications
Commonly used in radiotherapy for planning treatments involving high-density materials or complex anatomical structures. It is applied in scenarios like stereotactic radiosurgery and spine SBRT with hardware.
Evidence Summary
The literature includes 10 studies, ranging from 2017 to 2024, encompassing various study types. These studies focus on the accuracy and validation of the AAA algorithm in different clinical settings.
Reported Outcomes
Published studies report that the Eclipse AAA algorithm provides variable accuracy in dose calculations, particularly in the presence of high-density materials. It is generally effective in standard scenarios but may require careful consideration in complex cases.
Safety Profile
Reported complications include potential inaccuracies in dose calculation when high-density materials are involved, which could impact treatment efficacy and safety. No direct adverse events were noted in the studies.
Evidence Limitations
The evidence highlights gaps in understanding the algorithm's performance in non-standard scenarios, such as those involving dental amalgam or titanium hardware. Further research is needed to optimize its use in these contexts.
Frequently Asked Questions
What are the clinical indications for Eclipse with AAA?
Eclipse with AAA is indicated for use in radiotherapy treatment planning, particularly in scenarios requiring precise dose calculations, such as stereotactic radiosurgery and treatments involving high-density materials.
What outcomes have been reported in clinical studies?
Studies report that Eclipse with AAA generally provides accurate dose calculations, though challenges exist in scenarios with high-density materials, impacting treatment precision.
What complications have been reported?
Safety data indicates potential inaccuracies in dose calculations with high-density materials, which could affect treatment outcomes, though no direct adverse events were reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.